Bijan Ahvazi

Array ( [id] => 7685237 [patent_doc_number] => 20100120904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'NOVEL USE OF GENISTEIN' [patent_app_type] => utility [patent_app_number] => 12/594284 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2304 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120904.pdf [firstpage_image] =>[orig_patent_app_number] => 12594284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222912 [patent_doc_number] => 20100056522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/450388 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75512 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056522.pdf [firstpage_image] =>[orig_patent_app_number] => 12450388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675590 [patent_doc_number] => 20080213219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione' [patent_app_type] => utility [patent_app_number] => 12/077412 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12013 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213219.pdf [firstpage_image] =>[orig_patent_app_number] => 12077412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759968 [patent_doc_number] => 20080312194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods and compositions for normalizing meibomian gland secretions' [patent_app_type] => utility [patent_app_number] => 12/074028 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10120 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312194.pdf [firstpage_image] =>[orig_patent_app_number] => 12074028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867494 [patent_doc_number] => 20080146553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Antibiotic compostions and methods for using same' [patent_app_type] => utility [patent_app_number] => 12/070854 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5668 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146553.pdf [firstpage_image] =>[orig_patent_app_number] => 12070854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872803 [patent_doc_number] => 20080199537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'TOPICAL GATIFLOXACIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/031772 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1320 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199537.pdf [firstpage_image] =>[orig_patent_app_number] => 12031772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685233 [patent_doc_number] => 20100120908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'EYE DROP PREPARATION COMPRISING LATANOPROST' [patent_app_type] => utility [patent_app_number] => 12/526349 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15003 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120908.pdf [firstpage_image] =>[orig_patent_app_number] => 12526349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834029 [patent_doc_number] => 20080132576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING ALPHA ADRENERGIC RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/024609 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5904 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132576.pdf [firstpage_image] =>[orig_patent_app_number] => 12024609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904652 [patent_doc_number] => 20080114066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function' [patent_app_type] => utility [patent_app_number] => 12/014327 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15239 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114066.pdf [firstpage_image] =>[orig_patent_app_number] => 12014327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5447035 [patent_doc_number] => 20090048261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Pharmaceutical Composition for Treatment of Ocular Hypertension' [patent_app_type] => utility [patent_app_number] => 12/013403 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3132 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048261.pdf [firstpage_image] =>[orig_patent_app_number] => 12013403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453308 [patent_doc_number] => 20090069345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine' [patent_app_type] => utility [patent_app_number] => 12/013405 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2091 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069345.pdf [firstpage_image] =>[orig_patent_app_number] => 12013405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343283 [patent_doc_number] => 20090181933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'USE OF STEROIDS TO TREAT PERSONS SUFFERING FROM OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/013058 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2863 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181933.pdf [firstpage_image] =>[orig_patent_app_number] => 12013058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894112 [patent_doc_number] => 20080103211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'USE OF BETA-ADRENOCEPTOR ANTAGONISTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISORDERS OF THE OUTER RETINA' [patent_app_type] => utility [patent_app_number] => 11/969346 [patent_app_country] => US [patent_app_date] => 2008-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4754 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103211.pdf [firstpage_image] =>[orig_patent_app_number] => 11969346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916377 [patent_doc_number] => 20080096978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'OPHTHALMIC SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 11/961034 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2416 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096978.pdf [firstpage_image] =>[orig_patent_app_number] => 11961034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546710 [patent_doc_number] => 20090156587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Eye Medication Formulation with Antibacterial Agent' [patent_app_type] => utility [patent_app_number] => 11/959418 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156587.pdf [firstpage_image] =>[orig_patent_app_number] => 11959418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745351 [patent_doc_number] => 20080089953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Self-Preserved Ophthalmic Pharmaceutical Compositions Containing Tobramycin' [patent_app_type] => utility [patent_app_number] => 11/955046 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4294 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089953.pdf [firstpage_image] =>[orig_patent_app_number] => 11955046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009460 [patent_doc_number] => 08524758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia' [patent_app_type] => utility [patent_app_number] => 12/519910 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1337 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114915 [patent_doc_number] => 08158679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases' [patent_app_type] => utility [patent_app_number] => 12/515142 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2092 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158679.pdf [firstpage_image] =>[orig_patent_app_number] => 12515142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598412 [patent_doc_number] => 20100048705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'METHODS OF TREATING AND PREVENTING NEOVASCULARIZATION WITH OMEGA-3 POLYUNSATURATED FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 12/447768 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14349 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048705.pdf [firstpage_image] =>[orig_patent_app_number] => 12447768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899834 [patent_doc_number] => 20080119448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Methods of treating an ocular allergy with low dose dexamethasone' [patent_app_type] => utility [patent_app_number] => 11/979356 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4680 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119448.pdf [firstpage_image] =>[orig_patent_app_number] => 11979356 [rel_patent_id] =>[rel_patent_doc_number] =>)